Fund HoldingsACORN CAPITAL ADVISORS, LLC

Total Portfolio Value
$149.95M
Total Bought
$30.13M
Total Sold
$4.91M
Net Transaction
+$25.22M
Filing Period:
Securities
SharesValue ($K)
Q4 2024
Q1 2025
Change
Q4 2024
Q1 2025
Weight (%)
Change
TREVI THERAPEUTICS INC(TRVI)2,001,0482,144,844+143,7968,24413,4919.00%+5,247
VERASTEM INC0779,498+779,49804,7003.13%+4,700
AURA BIOSCIENCES INC0590,508+590,50801,4530.97%+1,453
OPTINOSE INC422,813422,814+12,8243,8772.59%+1,053
UROGEN PHARMA LTD(URGN)1,516,3031,516,303016,14916,77011.18%+622
VYNE THERAPEUTICS INC456,970785,938+328,9681,5311,2420.83%-289
PUMA BIOTECHNOLOGY INC3,940,0523,940,052012,01711,6637.78%-355
VERASTEM INC779,4980-779,4987790-779
BIOATLA INC4,032,0464,032,04602,3841,4110.94%-973
PROTARA THERAPEUTICS INC1,279,8001,279,80006,7575,4523.64%-1,305
Q32 BIO INC.803,425803,42502,7641,3260.88%-1,438
WHITEHAWK THERAPEUTICS INC1,147,0521,139,363-7,6893,6192,0281.35%-1,591
ACRIVON THERAPEUTICS INC405,237405,23702,4408230.55%-1,617
CARDIF ONCOLOGY INC1,442,3081,442,30806,2604,5293.02%-1,731
CYBIN INC734,393734,394+16,4774,6633.11%-1,814
MURAL ONCOLOGY PLC1,286,0791,269,715-16,3644,1411,6001.07%-2,541
BICARA THERAPEUTICS643,381643,382+111,2088,3835.59%-2,824
X4 PHARMACEUTICALS INC7,310,6507,310,65005,3631,7551.17%-3,609
CANDEL THERAPEUTICS INC1,939,6442,152,252+212,60816,83612,1608.11%-4,676
CG ONCOLOGY INC(CGON)1,131,5011,131,501032,45127,72218.49%-4,730
ONKURE THERAPEUTICS INC1,439,6741,439,674010,2485,1243.42%-5,124
TERNS PHARMACEUTICALS INC1,971,2641,971,264010,9215,4413.63%-5,480
Y-MABS THERAPEUTICS INC2,861,8253,235,387+373,56222,40814,3339.56%-8,075
Page 1 of 1